{"id":1557,"date":"2025-01-26T09:06:11","date_gmt":"2025-01-26T09:06:11","guid":{"rendered":"https:\/\/peritonealcancerinstitute.com\/pipac-indicacoes-e-contraindicacoes\/"},"modified":"2025-01-26T09:06:11","modified_gmt":"2025-01-26T09:06:11","slug":"pipac-indicacoes-e-contraindicacoes","status":"publish","type":"post","link":"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/","title":{"rendered":"PIPAC: indica\u00e7\u00f5es e contraindica\u00e7\u00f5es"},"content":{"rendered":"<h2><b>O que \u00e9 PIPAC<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/h2>\n<p><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) \u00e9 uma t\u00e9cnica de tratamento m\u00e9dico desenvolvida para administrar a quimioterapia diretamente na cavidade peritoneal (a \u00e1rea que abriga os \u00f3rg\u00e3os abdominais) de forma mais direcionada. Ela envolve o uso de um spray de aerossol para distribuir medicamentos quimioter\u00e1picos no espa\u00e7o peritoneal sob alta press\u00e3o. Esse m\u00e9todo visa melhorar a efic\u00e1cia da quimioterapia para pacientes com carcinomatose peritoneal, que inicialmente n\u00e3o s\u00e3o candidatos a uma cirurgia citorredutora completa com HIPEC (CRS+HIPEC).    <\/span><\/p>\n<p><span style=\"font-weight: 400;\">A PIPAC \u00e9 normalmente realizada quando um paciente tem carcinomatose peritoneal avan\u00e7ada, que se refere \u00e0 dissemina\u00e7\u00e3o de c\u00e9lulas cancerosas dentro da cavidade peritoneal. Isso pode ocorrer em c\u00e2nceres como o de ov\u00e1rio, g\u00e1strico, colorretal, de ap\u00eandice ou, menos comumente, em c\u00e2nceres hepatobiliares e pancre\u00e1ticos.   <\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">A PIPAC \u00e9 geralmente considerada quando outras op\u00e7\u00f5es de tratamento, como quimioterapia sist\u00eamica ou cirurgia citorredutora, s\u00e3o ineficazes ou invi\u00e1veis naquele momento, devido \u00e0 extens\u00e3o da doen\u00e7a.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><b>Tipos de c\u00e2ncer que podem ser tratados com o PIPAC:<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">O PIPAC tem sido usado com sucesso para tratar uma variedade de c\u00e2nceres abdominais, especialmente aqueles com dissemina\u00e7\u00e3o peritoneal. Os c\u00e2nceres comuns tratados com PIPAC incluem: <\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h3><b>C\u00e2ncer de ov\u00e1rio:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Frequentemente apresenta met\u00e1stase peritoneal, e o PIPAC pode ser \u00fatil quando as terapias tradicionais n\u00e3o s\u00e3o eficazes.<\/span><\/p>\n<p>&nbsp;<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h3><b>C\u00e2ncer g\u00e1strico:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Principalmente nos casos em que o c\u00e2ncer se espalhou pelo perit\u00f4nio.<\/span><\/p>\n<p>&nbsp;<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h3><b>C\u00e2ncer colorretal:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Em est\u00e1gios avan\u00e7ados com carcinomatose peritoneal, quando outros tratamentos n\u00e3o s\u00e3o vi\u00e1veis.<\/span><\/p>\n<p>&nbsp;<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h3><b>C\u00e2ncer de ap\u00eandice:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Que tamb\u00e9m pode causar dissemina\u00e7\u00e3o peritoneal, semelhante a outros c\u00e2nceres gastrointestinais.<\/span><\/p>\n<p>&nbsp;<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h3><b>Mesotelioma peritoneal:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Embora raro, esse c\u00e2ncer afeta diretamente o perit\u00f4nio e pode se beneficiar do PIPAC.<\/span><\/p>\n<p>&nbsp;<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h3><b>Pancre\u00e1tico<\/b><span style=\"font-weight: 400;\"> ou <\/span><b>c\u00e2nceres do trato biliar <\/b><span style=\"font-weight: 400; font-size: 16px;\">que se espalharam para o perit\u00f4nio.<\/span><\/h3>\n<p><span style=\"font-weight: 400;\"> <\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h3><b>Outros c\u00e2nceres abdominais avan\u00e7ados<\/b><span style=\"font-weight: 400;\"> <\/span><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">O PIPAC \u00e9 usado principalmente em um <\/span><b>paliativo<\/b><span style=\"font-weight: 400;\"> para controle dos sintomas e para retardar a progress\u00e3o da doen\u00e7a, e n\u00e3o como tratamento neoadjuvante. Ele oferece uma alternativa aos pacientes que t\u00eam poucas op\u00e7\u00f5es de tratamento.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><b>Indica\u00e7\u00f5es para a PIPAC:<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h3><b>Ambiente paliativo:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">O PIPAC \u00e9 principalmente um <\/span><b>paliativo<\/b><span style=\"font-weight: 400;\"> O objetivo \u00e9 aliviar os sintomas, melhorar a qualidade de vida (como evitar dor, obstru\u00e7\u00e3o intestinal, ascite) e prolongar a expectativa de vida, em vez de curar a doen\u00e7a. Ela \u00e9 usada quando as met\u00e1stases peritoneais n\u00e3o podem ser removidas cirurgicamente e a quimioterapia convencional \u00e9 menos eficaz ou n\u00e3o \u00e9 bem tolerada.<\/span><\/p>\n<p>&nbsp;<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h3><b>Tratamento neoadjuvante:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Em alguns casos, e nosso primeiro objetivo \u00e9 usar o PIPAC em combina\u00e7\u00e3o com quimioterapia sist\u00eamica ou cirurgia, para reduzir o est\u00e1gio da doen\u00e7a peritoneal e considerar a possibilidade de uma <\/span><b>cirurgia citorredutora (CRS)<\/b><span style=\"font-weight: 400;\"> e <\/span><b>quimioterapia intraperitoneal hipert\u00e9rmica (HIPEC).<\/b><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><b>Os candidatos ideais para a PIPAC incluem:<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h3><b>Pacientes com carcinomatose peritoneal que:  <\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">N\u00e3o podem ser submetidos ou n\u00e3o s\u00e3o candidatos \u00e0 <\/span><b>cirurgia citorredutora (CRS)<\/b><span style=\"font-weight: 400;\"> e <\/span><b>HIPEC<\/b><span style=\"font-weight: 400;\"> devido \u00e0 extens\u00e3o da doen\u00e7a ou a outros problemas de sa\u00fade.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Voc\u00ea tem uma doen\u00e7a que \u00e9 <\/span><b>refrat\u00e1ria<\/b><span style=\"font-weight: 400;\"> ou <\/span><b>resistente<\/b><span style=\"font-weight: 400;\"> \u00e0 quimioterapia sist\u00eamica ou quando a quimioterapia for mal tolerada.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Exigir <\/span><b>cuidados paliativos<\/b><span style=\"font-weight: 400;\"> para aliviar sintomas como dor, ascite ou obstru\u00e7\u00e3o intestinal.<\/span>&nbsp;<\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h3><b>Pacientes em um status de desempenho relativamente bom <\/b><span style=\"font-weight: 400; font-size: 16px;\">que podem tolerar procedimentos minimamente invasivos, como laparoscopia.<\/span><\/h3>\n<p><span style=\"font-weight: 400;\"> <\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h3><b>Pacientes com c\u00e2nceres abdominais disseminados <\/b><span style=\"font-weight: 400; font-size: 16px;\">quando os tratamentos sist\u00eamicos s\u00e3o menos eficazes ou causam efeitos colaterais intoler\u00e1veis.<\/span><\/h3>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><b>C<\/b><b>ontraindica\u00e7\u00f5es para a PIPAC<\/b><\/h2>\n<p><span style=\"font-weight: 400;\"><strong><a href=\"https:\/\/peritonealcancerinstitute.com\/pipac-treatment-success-rates-statistics\/\">Quimioterapia com aerossol intraperitoneal pressurizado<\/a><\/strong> (PIPAC) \u00e9 um tratamento especializado e certas contraindica\u00e7\u00f5es devem ser consideradas para garantir a seguran\u00e7a do paciente.<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">As contraindica\u00e7\u00f5es para o PIPAC podem ser categorizadas em <\/span><b>absolutas<\/b><span style=\"font-weight: 400;\"> absolutas e <\/span><b>relativas<\/b><span style=\"font-weight: 400;\"> absolutas e relativas:<\/span><\/p>\n<h3><b>Contraindica\u00e7\u00f5es absolutas:<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h4><b>Ades\u00f5es abdominais extensas<\/b><span style=\"font-weight: 400;\">:<\/span><\/h4>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Ader\u00eancias graves na cavidade abdominal podem impedir a distribui\u00e7\u00e3o uniforme da quimioterapia aerossolizada e prejudicar a efic\u00e1cia do procedimento.<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h4><b>Infec\u00e7\u00e3o sem controle<\/b><span style=\"font-weight: 400;\">:<\/span><\/h4>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Infec\u00e7\u00f5es ativas, especialmente na cavidade peritoneal ou na \u00e1rea abdominal, representam um risco significativo de complica\u00e7\u00f5es durante e ap\u00f3s o procedimento.<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h4><b>Obstru\u00e7\u00e3o intestinal<\/b><span style=\"font-weight: 400;\">:<\/span><\/h4>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">A obstru\u00e7\u00e3o total do intestino pode complicar o procedimento e aumentar o risco de perfura\u00e7\u00e3o ou outras complica\u00e7\u00f5es graves.<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h4><b>Condi\u00e7\u00f5es cardiopulmonares graves<\/b><span style=\"font-weight: 400;\">:<\/span><\/h4>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Os pacientes com doen\u00e7a card\u00edaca ou pulmonar significativa podem n\u00e3o tolerar a insufla\u00e7\u00e3o (introdu\u00e7\u00e3o de g\u00e1s) necess\u00e1ria durante o procedimento laparosc\u00f3pico, pois ela aumenta a press\u00e3o intra-abdominal e afeta a fun\u00e7\u00e3o cardiovascular e respirat\u00f3ria.<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h4><b>Doen\u00e7a em est\u00e1gio terminal ou status de desempenho ruim<\/b><span style=\"font-weight: 400;\">:<\/span><\/h4>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Pacientes com estado geral muito ruim ou aqueles que est\u00e3o nos est\u00e1gios terminais do c\u00e2ncer podem n\u00e3o ser candidatos adequados devido aos riscos potenciais que superam os benef\u00edcios do procedimento.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><b>Contraindica\u00e7\u00f5es relativas:<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h4><b>Ades\u00f5es moderadas<\/b><span style=\"font-weight: 400;\">:<\/span><\/h4>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Embora algumas ader\u00eancias possam ser controladas, ader\u00eancias moderadas podem complicar a aplica\u00e7\u00e3o do aerossol. Cada caso requer uma avalia\u00e7\u00e3o cuidadosa. <\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h4><b>Carga substancial de tumores<\/b><span style=\"font-weight: 400;\">:<\/span><\/h4>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Uma carga tumoral muito grande na cavidade peritoneal pode limitar a efic\u00e1cia do PIPAC. Nesses casos, o tratamento pode ser menos ben\u00e9fico. <\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h4><b>Desnutri\u00e7\u00e3o grave ou caquexia<\/b><span style=\"font-weight: 400;\">:<\/span><\/h4>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Os pacientes com perda de peso extrema ou estado nutricional ruim podem enfrentar riscos maiores durante a cirurgia e uma recupera\u00e7\u00e3o mais lenta. A otimiza\u00e7\u00e3o nutricional pode ser necess\u00e1ria antes de voc\u00ea considerar a PIPAC. <\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">\n<h4><b>Cirurgias abdominais anteriores<\/b><span style=\"font-weight: 400;\">:<\/span><\/h4>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Cirurgias anteriores extensas podem aumentar o risco de complica\u00e7\u00f5es devido ao tecido cicatricial ou \u00e0 anatomia alterada. \u00c9 necess\u00e1ria uma avalia\u00e7\u00e3o completa para determinar a viabilidade. <\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<div id=\"gtx-trans\" style=\"position: absolute; left: -2px; top: 1926.71px;\">\n<div class=\"gtx-trans-icon\"><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) \u00e9 uma t\u00e9cnica de tratamento m\u00e9dico desenvolvida para administrar a quimioterapia diretamente na cavidade peritoneal (a \u00e1rea que abriga os \u00f3rg\u00e3os abdominais) de forma mais direcionada. Ela envolve o uso de um spray de aerossol para distribuir medicamentos quimioter\u00e1picos no espa\u00e7o peritoneal sob alta press\u00e3o. Esse m\u00e9todo visa melhorar a efic\u00e1cia da quimioterapia para pacientes com carcinomatose peritoneal, que inicialmente n\u00e3o s\u00e3o candidatos a uma cirurgia citorredutora completa com HIPEC (CRS+HIPEC).    <\/p>\n","protected":false},"author":1,"featured_media":1555,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[28],"tags":[],"class_list":["post-1557","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sem-categoria"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tratamento para c\u00e2ncer peritoneal PIPAC: indica\u00e7\u00f5es e contraindica\u00e7\u00f5es<\/title>\n<meta name=\"description\" content=\"O PIPAC \u00e9 um tratamento minimamente invasivo e eficaz para a carcinomatose peritoneal, mas tem suas limita\u00e7\u00f5es. Saiba mais.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tratamento para c\u00e2ncer peritoneal PIPAC: indica\u00e7\u00f5es e contraindica\u00e7\u00f5es\" \/>\n<meta property=\"og:description\" content=\"O PIPAC \u00e9 um tratamento minimamente invasivo e eficaz para a carcinomatose peritoneal, mas tem suas limita\u00e7\u00f5es. Saiba mais.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/\" \/>\n<meta property=\"og:site_name\" content=\"Peritoneal Cancer Institute\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-26T09:06:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/peritonealcancerinstitute.com\/wp-content\/uploads\/2025\/03\/pipac-1-scaled-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1473\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/#\/schema\/person\/ec80000799b06948df7ae75a587e6fea\"},\"headline\":\"PIPAC: indica\u00e7\u00f5es e contraindica\u00e7\u00f5es\",\"datePublished\":\"2025-01-26T09:06:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/\"},\"wordCount\":965,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/#organization\"},\"image\":{\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/peritonealcancerinstitute.com\/wp-content\/uploads\/2025\/03\/pipac-1-scaled-1.jpg\",\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/\",\"url\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/\",\"name\":\"Tratamento para c\u00e2ncer peritoneal PIPAC: indica\u00e7\u00f5es e contraindica\u00e7\u00f5es\",\"isPartOf\":{\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/peritonealcancerinstitute.com\/wp-content\/uploads\/2025\/03\/pipac-1-scaled-1.jpg\",\"datePublished\":\"2025-01-26T09:06:11+00:00\",\"description\":\"O PIPAC \u00e9 um tratamento minimamente invasivo e eficaz para a carcinomatose peritoneal, mas tem suas limita\u00e7\u00f5es. Saiba mais.\",\"breadcrumb\":{\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#primaryimage\",\"url\":\"https:\/\/peritonealcancerinstitute.com\/wp-content\/uploads\/2025\/03\/pipac-1-scaled-1.jpg\",\"contentUrl\":\"https:\/\/peritonealcancerinstitute.com\/wp-content\/uploads\/2025\/03\/pipac-1-scaled-1.jpg\",\"width\":2560,\"height\":1473,\"caption\":\"Dr. Domenico Sabia operando\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PIPAC: indica\u00e7\u00f5es e contraindica\u00e7\u00f5es\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/#website\",\"url\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/\",\"name\":\"Peritoneal Cancer Institute\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/#organization\",\"name\":\"Peritoneal Cancer Institute\",\"url\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/peritonealcancerinstitute.com\/wp-content\/uploads\/2025\/11\/2.png\",\"contentUrl\":\"https:\/\/peritonealcancerinstitute.com\/wp-content\/uploads\/2025\/11\/2.png\",\"width\":364,\"height\":47,\"caption\":\"Peritoneal Cancer Institute\"},\"image\":{\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/#\/schema\/person\/ec80000799b06948df7ae75a587e6fea\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/peritonealcancerinstitute.com\/pt-br\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/40b2ed9847a2663b87bf71cf999564d46fe3544cdc0b3d2452a4054a69ea5f7e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/40b2ed9847a2663b87bf71cf999564d46fe3544cdc0b3d2452a4054a69ea5f7e?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/peritonealcancerinstitute.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tratamento para c\u00e2ncer peritoneal PIPAC: indica\u00e7\u00f5es e contraindica\u00e7\u00f5es","description":"O PIPAC \u00e9 um tratamento minimamente invasivo e eficaz para a carcinomatose peritoneal, mas tem suas limita\u00e7\u00f5es. Saiba mais.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/","og_locale":"pt_BR","og_type":"article","og_title":"Tratamento para c\u00e2ncer peritoneal PIPAC: indica\u00e7\u00f5es e contraindica\u00e7\u00f5es","og_description":"O PIPAC \u00e9 um tratamento minimamente invasivo e eficaz para a carcinomatose peritoneal, mas tem suas limita\u00e7\u00f5es. Saiba mais.","og_url":"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/","og_site_name":"Peritoneal Cancer Institute","article_published_time":"2025-01-26T09:06:11+00:00","og_image":[{"width":2560,"height":1473,"url":"https:\/\/peritonealcancerinstitute.com\/wp-content\/uploads\/2025\/03\/pipac-1-scaled-1.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admin","Est. tempo de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#article","isPartOf":{"@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/"},"author":{"name":"admin","@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/#\/schema\/person\/ec80000799b06948df7ae75a587e6fea"},"headline":"PIPAC: indica\u00e7\u00f5es e contraindica\u00e7\u00f5es","datePublished":"2025-01-26T09:06:11+00:00","mainEntityOfPage":{"@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/"},"wordCount":965,"commentCount":0,"publisher":{"@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/#organization"},"image":{"@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#primaryimage"},"thumbnailUrl":"https:\/\/peritonealcancerinstitute.com\/wp-content\/uploads\/2025\/03\/pipac-1-scaled-1.jpg","inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/","url":"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/","name":"Tratamento para c\u00e2ncer peritoneal PIPAC: indica\u00e7\u00f5es e contraindica\u00e7\u00f5es","isPartOf":{"@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#primaryimage"},"image":{"@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#primaryimage"},"thumbnailUrl":"https:\/\/peritonealcancerinstitute.com\/wp-content\/uploads\/2025\/03\/pipac-1-scaled-1.jpg","datePublished":"2025-01-26T09:06:11+00:00","description":"O PIPAC \u00e9 um tratamento minimamente invasivo e eficaz para a carcinomatose peritoneal, mas tem suas limita\u00e7\u00f5es. Saiba mais.","breadcrumb":{"@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#primaryimage","url":"https:\/\/peritonealcancerinstitute.com\/wp-content\/uploads\/2025\/03\/pipac-1-scaled-1.jpg","contentUrl":"https:\/\/peritonealcancerinstitute.com\/wp-content\/uploads\/2025\/03\/pipac-1-scaled-1.jpg","width":2560,"height":1473,"caption":"Dr. Domenico Sabia operando"},{"@type":"BreadcrumbList","@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/pipac-indicacoes-e-contraindicacoes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/peritonealcancerinstitute.com\/pt-br\/"},{"@type":"ListItem","position":2,"name":"PIPAC: indica\u00e7\u00f5es e contraindica\u00e7\u00f5es"}]},{"@type":"WebSite","@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/#website","url":"https:\/\/peritonealcancerinstitute.com\/pt-br\/","name":"Peritoneal Cancer Institute","description":"","publisher":{"@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/peritonealcancerinstitute.com\/pt-br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/#organization","name":"Peritoneal Cancer Institute","url":"https:\/\/peritonealcancerinstitute.com\/pt-br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/#\/schema\/logo\/image\/","url":"https:\/\/peritonealcancerinstitute.com\/wp-content\/uploads\/2025\/11\/2.png","contentUrl":"https:\/\/peritonealcancerinstitute.com\/wp-content\/uploads\/2025\/11\/2.png","width":364,"height":47,"caption":"Peritoneal Cancer Institute"},"image":{"@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/#\/schema\/person\/ec80000799b06948df7ae75a587e6fea","name":"admin","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/peritonealcancerinstitute.com\/pt-br\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/40b2ed9847a2663b87bf71cf999564d46fe3544cdc0b3d2452a4054a69ea5f7e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/40b2ed9847a2663b87bf71cf999564d46fe3544cdc0b3d2452a4054a69ea5f7e?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/peritonealcancerinstitute.com"]}]}},"_links":{"self":[{"href":"https:\/\/peritonealcancerinstitute.com\/pt-br\/wp-json\/wp\/v2\/posts\/1557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/peritonealcancerinstitute.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/peritonealcancerinstitute.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/peritonealcancerinstitute.com\/pt-br\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/peritonealcancerinstitute.com\/pt-br\/wp-json\/wp\/v2\/comments?post=1557"}],"version-history":[{"count":0,"href":"https:\/\/peritonealcancerinstitute.com\/pt-br\/wp-json\/wp\/v2\/posts\/1557\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/peritonealcancerinstitute.com\/pt-br\/wp-json\/wp\/v2\/media\/1555"}],"wp:attachment":[{"href":"https:\/\/peritonealcancerinstitute.com\/pt-br\/wp-json\/wp\/v2\/media?parent=1557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/peritonealcancerinstitute.com\/pt-br\/wp-json\/wp\/v2\/categories?post=1557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/peritonealcancerinstitute.com\/pt-br\/wp-json\/wp\/v2\/tags?post=1557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}